Evidence map›Paper›PMID 39833699›Full record

ArticleBMC microbiology2025

Antibacterial activity of selenium nanoparticles/copper oxide (SeNPs/CuO) nanocomposite against some multi-drug resistant clinical pathogens.

Ahmed Morad Asaad, Sara A Saied, Mohammad M Torayah, N I Abu-Elsaad, Samah Mohammed Awad

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Engineering copper and copper-based materials for a post-antibiotic era.Frontiers in bioengineering and biotechnology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmed Morad AsaadMedical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. ahmedasaad@zu.edu.eg.ORCID 0000-0002-1422-1117
Sara A SaiedDepartment of Clinical Pathology, National Liver Institute, Menoufia University, Shibin el Kom, Egypt.ORCID 0009-0009-8183-7868
Mohammad M TorayahDepartment of Anaesthesia and Intensive care, critical care unit, Faculty of Medicine, Menoufia University, Shibin el Kom, Egypt.
N I Abu-ElsaadPhysics Department, Faculty of Science, Zagazig University, Zagazig, Egypt.
Samah Mohammed AwadClinical microbiology and immunology department, National liver institute, Menoufia University, Shibin el Kom, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent advances in nanomedicine have derived novel prospects for development of various bioactive nanoparticles and nanocomposites with significant antibacterial and antifungal properties. This study aims to investigate some characteristics of the novel Se-NPs/Cu

methodsThe Se-NPs/Cu

resultsThe Se-NPs/Cu

conclusionThese findings would support further research in development of a novel Se-NPs/Cu

Indexed as

Anti-Bacterial AgentsCopperDrug Resistance, Multiple, BacterialGram-Negative BacteriaGram-Positive BacteriaMetal NanoparticlesNanocompositesSeleniumHumansMicrobial Sensitivity TestsSpectroscopy, Fourier Transform InfraredX-Ray DiffractionAnti-Bacterial AgentsCoppercupric oxidecuprous oxideSeleniumCopper oxide nanoparticleMulti-drug resistant bacteriaNanomedicineSelenium nanoparticles

Identifiers

PMID39833699
PMCPMC11745003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.